Share

Dott. Vincenzo La Vaccara

Biography

Contract professor of Surgery is present at theUniversità Campus Bio-Medico di Roma since the 2013/2014 academic year with orientation and tutoring duties in the teaching of oncology surgery (SSD MED/18) for the Master's Degree course in Medicine and Surgery at the Departmental Faculty of Medicine and Surgery. From 2020/2021 he began the role of professor of Surgery for the Master's Degree course in Physiotherapy as part of the integrated exam in Oncology and First Aid.
After having obtained a degree in Medicine from the Campus Bio-Medico University, the specialization in General Surgery and the title of PhD, he carries out research activities in various fields of surgical sciences, with the production of about 50 papers in journals with Impact factor.

Curriculum

Since 2019 he has been carrying out a permanent contract as a doctor at the UOC of "General Surgery" of the Campus Bio-Medico University Hospital of Rome with the position of Head of Minor Professional Functions.
From 2016 to 2019 he carried out clinical and operating room activities with a paid freelance collaboration contract at the Campus Bio-Medico University Hospital of Rome in the UOC of "General Surgery" of the Campus Bio-Medico University Hospital of Rome.
After specializing in General Surgery at the Campus Bio-Medico University Hospital in Rome, from 2013 to 2016 he carried out clinical and operating room activities with a paid freelance collaboration contract both at the UOS of "Urology F" and at the the UOC of “Geriatric Surgery”.
After obtaining the Classical High School Diploma in 2000 at the “I. Kant” high school in Rome, in July 2006 he obtained the Degree in Medicine and Surgery with a grade of 110/110 and honors at theuniversità Campus Bio-Medico di Roma, discussing the thesis “Prognostic value of the Cyr61 protein in patients radically operated for adenocarcinoma of the pancreas and ampulla. Multicenter study”.
During her degree, she carried out a period of international research both at the "Klinik und Poliklinik fur Allgemein-Viszeral-und Thoraxchirurgie" of the University of Hamburg and the "Division of Organ Transplantation - Department of Surgery" of the University of Massachusetts.
Having obtained the qualification to practice medicine in March 2007, he enrolled in the register of doctors of Rome no. 55631.
Admitted in 2008 to the specialization school in General Surgery at theuniversità Campus Bio-Medico di Roma, in August 2013, obtained the title of specialist with a grade of 70/70 cum laude, discussing the thesis “Laparoscopic access in principle in surgery of the left colon and rectum: analysis of three years of experience at the Campus Bio-Medico”.
During the School of Specialization in General Surgery he attended the General Surgery department at the “S. Giovanni Evangelista” of Tivoli (RM), participating in the surgical activities of the emergency room, ward and operating room.
In July 2018 he obtained the PhD in Integrated Biomedical Sciences and Bioethics-Osteo-Oncological Pathology (XXX cycle year 2014/2015) and subsequently obtained the SIUMB National Diploma of competence in Clinical Ultrasound.
In 2022 and 2023 he actively participated in the Scientific Secretariat of the following two international conferences held at the premises of theUniversità Campus Bio-Medico di Roma :
1. “Minimally Invasive Surgery of the Pancreas”
A congress held from 28 to 29 April 2022 on the scientific evidence that led to the recent production of international guidelines in the field of minimally invasive surgery for pancreatic neoplasms.
2. "Robotics and technologies in general surgery"
An international training event held from 25 to 26 May 2023 aimed at analyzing the state of the art and future prospects of robotic surgery in general surgery with particular reference to pathologies of surgical interest in the endocrine-metabolic, gastrointestinal and hepatobiliary-pancreatic fields.

He is a member of the following national and international surgical societies:
Italian Society of Surgery (SIC)
Fellow of American College of Surgeons (ACS)
European Society of Surgical Oncology (ESSO)

PUBLICATIONS

1. National Institute for Health and Care Research Global Health Research Unit on Global Surgery. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. Br J Surg. 2023 Jun 12;110(7):804-817.
2. Coppola A, Farolfi T, La Vaccara V, Iannone I, Giovinazzo F, Panettieri E, Tarallo M, Cammarata R, Coppola R, Caputo D. Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going. J Clin Med. 2023 May 25;12(11):3677.
3. Lottini T, Duranti C, Iorio J, Martinelli M, Colasurdo R, D'Alessandro FN, et al. Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. Cancers. March 28, 2023;15(7):2013.
4. Coppola A, La Vaccara, Angeletti S, Spoto S, Farolfi T, Cammarata R, et al. Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Oncol. January 2023;0 (0):0–0.
5. La Vaccara V, Cascone C, Coppola A, Farolfi T, Cammarata R, Emerenziani S, et al. Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer. Ann Ital Chir. 2023;94:45–51.
6. Manuel-Vazquez A, Balakrishnan A, Agami P, Andersson B, Berrevoet F, Besselink MG, et al. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation. Langenbecks Arch Surg. December 2022;407(8):3447–55.
7. Coppola A, Farolfi T, La Vaccara V, Cammarata R, Caputo D. Role of Neoplastic Markers in Pancreatic Adenocarcinoma. J Clin Med. 2 November 2022;11(21):6509.
8. La Vaccara V, Farolfi T, Coppola A, Cammarata R, Carbone L, Marano L, et al. Postoperative Day 3 Serum Lipase Level as an Easy and Reliable Predictor of Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy. Journal of the American College of Surgeons. November 2022;235(5):S88–S88.
9. La Vaccara V, Coppola A, Farolfi T, Cammarata R, Olivieri L, Damone G, et al. Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis. Journal of the American College of Surgeons. November 2022;235(5):S80–1.
10. La Vaccara V, Cammarata R, Coppola A, Farolfi T, Carbone L, Marano L, et al. Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy. Journal of the American College of Surgeons. November 2022;235(5):S88–9.
11. Coppola A, Cammarata R, La Vaccara V, Farolfi T, Caputo D. New Frontiers of Early Diagnosis of Pancreatic Fistula after Pancreaticoduodenectomy. J Clin Med. Oct 29, 2022;11(21):6423.
12. Coppola A, La Vaccara V, Farolfi T, Fiore M, Cammarata R, Ramella S, et al. Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives. Biomedicines. August 26, 2022;10(9):2091.
13. Coppola A, Fiore M, La Vaccara V, Farolfi T, Caputo D, Ramella S. Special Issue «Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments». J Clin Med. Jul 2, 2022;11(13):3849.
14. La Vaccara V, Cammarata R, Coppola A, Farolfi T, Cascone C, Angeletti S, et al. Data of postoperative complications related to fibrinogen-to-albumin ratio in pancreatic resections. Data Brief. June 2022;42:108064.
15. Capolupo GT, Galvain T, Parago V, Tong C, Masciana G, Di Berardino S, et al. In-hospital economic burden of anastomotic leakage after colorectal anastomosis surgery: a real-world cost analysis in Italy. Expert Rev Pharmcoecon Outcomes Res. June 2022;22(4):691–7.

Roles in the University

QUICK LINKS
[] magnifiercrossmenuchevron-downchevron-leftchevron-right